No abstract available.
Hantaan virus* ; Hemorrhagic Fever with Renal Syndrome*

No abstract available.
Female ; Glaucoma, Angle-Closure/complications/surgery ; Humans ; Middle Aged ; Optic Neuropathy, Ischemic/complications/*diagnosis

No abstract available.
Female ; Glaucoma, Angle-Closure/complications/surgery ; Humans ; Middle Aged ; Optic Neuropathy, Ischemic/complications/*diagnosis

No abstract available.
Aging* ; Erythrocytes* ; Humans ; Lipid Peroxidation*

No abstract available.
Carcinoma, Mucoepidermoid*

The aim of this in vitro study was to evaluate the suitability of using chitosan, poly (lactide-co-glycolide) (PLGA), and polymethyl methacrylate (PMMA) to control the release of chlorhexidine digluconate (CHX) from a prototype of controlled release drug device (CRD) for root canal disinfection. Four different prototypes with different formulations were prepared. Group A (n = 12); The device (absorbent paper point) was loaded with CHX as control. Group B (n = 12); same as group A, but the device was coated with chitosan. In Groups C and D, the device was treated in the same way as group A and then coated three times with 5% PMMA (Group C, n = 12), or coated three times with 3% PLGA (Group D, n = 12). The devices were randomly allocated to experimental groups of 12 each. All CRD prototypes were soaked in 3 mL distilled water. The concentrations of CHX were determined using a UV spectrophotometer. The surface characteristics of each prototype were observed using a scanning electron microscope. The result showed that release rate of CHX was the greatest in the non-coated group, followed by the chitosan-coated group, the PLGA-coated group, and the PMMA-coated group (P < 0.05). Pores were observed on the surface of the prototypes that were coated with PLGA and PMMA. When the pore size was smaller, the release rate was lower. This data indicate that polymer coating can control the release rate of CHX from the CRD prototypes.
Chitosan ; Chlorhexidine* ; Dental Pulp Cavity* ; Disinfection* ; Polymers* ; Polymethyl Methacrylate ; Water

PURPOSE: To report a case of unilateral nasal hemianopsia caused by a large internal carotid artery aneurysm. CASE SUMMARY: A 56-year-old female presented with large cupping in the left optic nerve head detected incidentally during a routine check-up. She had no underlying systemic disease except hypertension. The best corrected visual acuity was 20/20 in both eyes and a slit-lamp examination showed no abnormal findings. Ophthalmoscopy showed cup/disc ratios of 0.6 in the right eye and 0.75 in the left eye. Relative afferent papillary defect or color vision defect was not observed. A Humphrey visual-field test indicated unilateral nasal hemianopsia in the left eye. Brain CT and angiography revealed a large 2.2-cm aneurysm on the left internal carotid artery. CONCLUSIONS: Internal carotid artery aneurysm should be considered as a possible cause of unilateral nasal hemianopsia in patients without intraocular lesion.
Aneurysm* ; Angiography ; Brain ; Carotid Artery, Internal* ; Color Vision Defects ; Female ; Hemianopsia* ; Humans ; Hypertension ; Middle Aged ; Ophthalmoscopy ; Optic Disk ; Visual Acuity

Providing visual information about the fetus to the mother by the ultrasound examination was found to be an effective nursing intervention to promote Maternal-Fetal Attachment. In keeping with the purpose of the study, to evaluate the effect of providing visual information by ultrasound on level of Maternal-Fetal Attachment, a non-equivalent experimental group quasi-experimental design was used. The data were collected using Cranley's Maternal-Fetal Attachment Scale(1981) with a research questionnaire that consisted of 16 items on general characteristics and 23 items on Maternal-Fetal Attachment from November 2, 2000 to August 11, 2001. Subjects were 126 pregnant women who were received visual information by ultrasound and 123 pregnant women who did not receive visual information by ultrasound after finishing examination. The data were analyzed by using the SPSS/PC+ window 10.0 version program. The results of this study were as follows: There was no statistical difference in general characteristics between both groups. The scores on Maternal-Fetal Attachment at second trimester show no statistical difference (t=1.123, p=0.263). The scores on Maternal- Fetal Attachment in both groups increased between the second trimester and third trimester. However, the increase was greater in the group receiving visual information by ultrasound as compared to the group which did not receive the visual information(t=-2.152, p=0.032). This result shows that providing visual information about the fetus by the ultrasound examination is effective in increasing Maternal-Fetal Attachment.
Female ; Fetus ; Humans ; Mothers ; Nursing ; Pregnancy ; Pregnancy Trimester, Second ; Pregnancy Trimester, Third ; Pregnant Women ; Surveys and Questionnaires ; Ultrasonography*

Pulmonary alveolar proteinosis (PAP) is a rare condition that is treated using whole lung lavage. A recent study suggested that granulocyte-macrophage colony stimulating factor (GM-CSF) plays roles in both the pathogenesis and treatment of PAP. We present a 69-year-old man with PAP who deteriorated despite bilateral whole lung lavage; that said, his symptoms, chest X-ray findings, and pulmonary function test improved after GM-CSF inhalation therapy over 12 months. GM-CSF therapy is an effective treatment modality for PAP.
Aged ; Bronchoalveolar Lavage ; Colony-Stimulating Factors ; Granulocyte-Macrophage Colony-Stimulating Factor ; Humans ; Inhalation ; Lung ; Pulmonary Alveolar Proteinosis ; Respiratory Function Tests ; Respiratory Therapy ; Thorax

Recently, loss of endogenous glutathione during N-methyl-D-aspartate (NMDA) receptor-mediated excitotoxic injury, and the resultant overproduction of reactive oxygen species (ROS) through an arachidonic acid cascade process in brain, have been implicated in neuronal damage in various neurodegenerative diseases. Glutathione depletion induced by L-buthionine-(S,R)-sulfoximine (BSO), an inhibitor of glutathione synthesis, is known to cause arachidonic acid-mediated excitotoxicity in primary mixed cortical cultures. The aim of this study was to investigate whether esculetin (6,7-dihydroxycoumarin), an inhibitor of lipoxygenase, protects against neurotoxicity induced by NMDA or BSO. We observed that neurotoxicity induced by NMDA but not kainic acid was attenuated by esculetin. At the same concentration (100 microM), esculetin attenuated the 45Ca2+ uptake elevation induced by NMDA. Free radical-mediated neuronal injury induced by H2O2 and xanthine/xanthine oxidase was concentration-dependently blocked by esculetin. Esculetin (1-30 microM) dose-dependently inhibited BSO-induced neuronal injury. In addition, arachidonate-induced neurotoxicity was completely blocked by esculetin. BSO also reduced glutathione peroxidase (GPx) activity, but did not change glutathione reductase (GR) activity 24 h after treatment. Esculetin dose-dependently increased GR activity, but did not alter GPx activity. These findings suggest that esculetin can contribute to the rescue of neuronal cells from NMDA neurotoxicity and that this protective effect occurs partly through NMDA receptor modulation and the sparing of glutathione depletion.
Arachidonic Acid ; Brain ; Glutathione ; Glutathione Reductase ; Kainic Acid ; Lipoxygenase ; N-Methylaspartate ; Neurodegenerative Diseases ; Neurons ; Oxidoreductases ; Peroxidase ; Reactive Oxygen Species ; Umbelliferones